doi:10.12965/jer.2244004.002
Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies can mass produce and distribute versions of FDA-approved drugs only if those drugs are designated by the FDA as being in shortage
Gauderer MW, Crane MM, Green JA, et al
At Angel Reyes & Associates, we see every case as an opportunity to make a positive difference in our clients lives
Sensitive compounds are shipped using temperature-controlled packaging, including dry ice or insulated cooling materials, to help preserve integrity until delivery
Given this timeline, the cost difference between brand-name Ozempic and affordable alternatives becomes enormous: 18 months of brand-name costs $17,442 versus $3,582 for compounded alternatives, a difference of $13,860